BioAge Labs, Inc. Common Stock (BIOA)
PHARMACEUTICAL PREPARATIONS
BioAge Labs, Inc. Common Stock (BIOA) is listed on Nasdaq, where it has traded since September 26, 2024.
- Listed On
- Nasdaq
- Listed Since
- September 26, 2024
- Employees
- 62
- Market Cap
- $274M
About BioAge Labs, Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 147 institutions reported holding BIOA, with 37.7 million shares worth $924.6 million in aggregate. The largest reported holder was AH Capital Management, with 3.2 million shares worth $79.2 million. Of the 5 largest holders listed below, 2 added shares, 1 reduced its position and 2 held their positions unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| AH Capital Management | 3,233,170 | $79M | Unchanged |
| BlackRock | 2,849,077 | $70M | Added 25.63% |
| Cormorant Asset Management | 2,390,605 | $59M | Reduced 17.3% |
| Sofinnova Investments | 2,293,788 | $56M | Unchanged |
| Vanguard | 2,205,844 | $54M | Added 18.53% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is BIOA?
BioAge Labs, Inc. Common Stock (BIOA) is listed on Nasdaq, where it has traded since September 26, 2024.
Who are the largest institutional holders of BIOA?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of BIOA were AH Capital Management, BlackRock and Cormorant Asset Management.
How many institutions own BIOA?
147 institutions reported a position in BIOA for the quarter ended June 30, 2026, worth $924.6 million in total.
Did institutions buy or sell BIOA last quarter?
Of the 5 largest reported holders, 2 added shares, 1 reduced its position and 2 held their positions unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for BIOA.
Every reported institutional holder, plus insider and congressional trades in BIOA, on SentiSense.